MA41855A - Procédé pour la fabrication de mélanges de poudres sèches - Google Patents
Procédé pour la fabrication de mélanges de poudres sèchesInfo
- Publication number
- MA41855A MA41855A MA041855A MA41855A MA41855A MA 41855 A MA41855 A MA 41855A MA 041855 A MA041855 A MA 041855A MA 41855 A MA41855 A MA 41855A MA 41855 A MA41855 A MA 41855A
- Authority
- MA
- Morocco
- Prior art keywords
- mixtures
- manufacture
- dry powders
- powders
- dry
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN380KO2015 | 2015-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA41855A true MA41855A (fr) | 2021-03-31 |
Family
ID=56024334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA041855A MA41855A (fr) | 2015-04-01 | 2016-04-01 | Procédé pour la fabrication de mélanges de poudres sèches |
Country Status (14)
Country | Link |
---|---|
US (1) | US10617646B2 (fr) |
EP (1) | EP3277265A1 (fr) |
CN (1) | CN107864622A (fr) |
AU (1) | AU2016241369A1 (fr) |
BR (1) | BR112017021111A2 (fr) |
CA (1) | CA2981440A1 (fr) |
CL (1) | CL2017002470A1 (fr) |
CO (1) | CO2017011220A2 (fr) |
EA (1) | EA201792159A1 (fr) |
IL (1) | IL254814A0 (fr) |
MA (1) | MA41855A (fr) |
MD (1) | MD20170094A2 (fr) |
MX (1) | MX2017012633A (fr) |
WO (1) | WO2016156970A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019067708A1 (fr) * | 2017-09-27 | 2019-04-04 | Teva Branded Pharmaceutical Products R&D, Inc. | Procédé pour diminuer la taille de particules |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0324897D0 (en) * | 2003-10-24 | 2003-11-26 | Glaxo Group Ltd | Composition |
BRPI0819259A2 (pt) * | 2007-11-07 | 2019-10-01 | Astrazeneca Ab | formulações de pó seco compreendendo derivados do ácido ascórbico. |
WO2013091006A1 (fr) * | 2011-12-23 | 2013-06-27 | Monash University | Procédé de mélange de poudre sèche |
GB201205632D0 (en) * | 2012-03-30 | 2012-05-16 | Vectura Ltd | Method and apparatus |
WO2015034678A2 (fr) * | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles |
-
2016
- 2016-04-01 CA CA2981440A patent/CA2981440A1/fr not_active Abandoned
- 2016-04-01 MA MA041855A patent/MA41855A/fr unknown
- 2016-04-01 CN CN201680032256.8A patent/CN107864622A/zh active Pending
- 2016-04-01 AU AU2016241369A patent/AU2016241369A1/en not_active Abandoned
- 2016-04-01 WO PCT/IB2016/000418 patent/WO2016156970A1/fr active Application Filing
- 2016-04-01 EP EP16723817.9A patent/EP3277265A1/fr not_active Withdrawn
- 2016-04-01 MX MX2017012633A patent/MX2017012633A/es unknown
- 2016-04-01 US US15/563,281 patent/US10617646B2/en active Active
- 2016-04-01 EA EA201792159A patent/EA201792159A1/ru unknown
- 2016-04-01 BR BR112017021111A patent/BR112017021111A2/pt not_active Application Discontinuation
- 2016-04-01 MD MDA20170094A patent/MD20170094A2/ro not_active Application Discontinuation
-
2017
- 2017-09-29 CL CL2017002470A patent/CL2017002470A1/es unknown
- 2017-10-01 IL IL254814A patent/IL254814A0/en unknown
- 2017-10-31 CO CONC2017/0011220A patent/CO2017011220A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2016241369A1 (en) | 2017-11-02 |
CN107864622A (zh) | 2018-03-30 |
US20180071218A1 (en) | 2018-03-15 |
EA201792159A1 (ru) | 2018-01-31 |
BR112017021111A2 (pt) | 2018-07-03 |
CL2017002470A1 (es) | 2018-04-13 |
MX2017012633A (es) | 2018-06-20 |
IL254814A0 (en) | 2017-12-31 |
WO2016156970A1 (fr) | 2016-10-06 |
CA2981440A1 (fr) | 2016-10-06 |
US10617646B2 (en) | 2020-04-14 |
EP3277265A1 (fr) | 2018-02-07 |
MD20170094A2 (ro) | 2018-04-30 |
CO2017011220A2 (es) | 2018-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201700367YA (en) | Process for the production of cementitious material | |
GB2558335B (en) | Novel processes for the production of oligonucleotides | |
GB2550003B (en) | Process for the production of formaldehyde-stabilised urea | |
IL265239A (en) | A process for the production of a solid pharmaceutical preparation | |
FR3035400B1 (fr) | Procede de fabrication de methionine | |
FR3030502B1 (fr) | Procede de fabrication d'une piece en materiau composite | |
DK3359522T3 (da) | Proces til fremstilling af N-Boc-bifenylalaninol | |
IL264074B (en) | Industrial process for the preparation of caprazine | |
ZA201902125B (en) | Process for the production of 2-alkylalkanol | |
HK1254793A1 (zh) | 生產高純度硫酸化ha的改進方法 | |
ZA201601869B (en) | Improved process for the preparation of apremilast | |
FI20155241A (fi) | Menetelmä beta-spodumeenin valmistamiseksi alfa-spodumeenia sisältävästä raaka-aineesta | |
DK3495339T3 (da) | Fremgangsmåde til fremstilling af reaktionsprodukt | |
FR3027834B1 (fr) | Procede de densification de poudres de polyarylene-ether-cetone | |
MA47409A (fr) | Nouveau procédé de synthèse de 1-aryl-1-trifluorométhylcyclopropanes | |
MA46454A (fr) | Procédé multi-protéase | |
MA44680A (fr) | Compositions et procédés pour la production de composés | |
FR3019817B1 (fr) | Procede de fabrication d'une piece en materiau composite multiperforee | |
PT3325704T (pt) | Máquina para a producção de calçado | |
FR3032144B1 (fr) | Procede de fabrication de pieces en materiau composite | |
MA49056A (fr) | Procédé de fabrication de la forme alpha de vortioxétine hbr | |
GB201619827D0 (en) | Process for the production of methyl methacrylate | |
MA41855A (fr) | Procédé pour la fabrication de mélanges de poudres sèches | |
DK3344048T3 (da) | Fremgangsmåde til fremstilling af mejeripulver | |
EP3419627C0 (fr) | Procédé de fabrication de composés antiviraux, tels que la triazavirine |